Today, March 6, 2023, is the last day of trading with the warrants of series TO13B in iZafe Group AB (“iZafe” or “the Company”). The subscription period for the warrants of series TO13B runs up until March 8, 2023. Each warrant of series TO13B gives the owner the right to subscribe for one (1) new share of series B in iZafe. The exercise price for the warrants of series TO13B is SEK 0.20 per share of series B.
If all the warrants of series TO13B are exercised, the Company will receive approximately SEK 23.7 million before issuing costs. In order to prevent the warrants expiring without value, the holder must actively subscribe for new shares, no later than March 8, 2023. Alternatively, the holder may sell the warrants, no later than today, March 6, 2023. Please be aware that certain nominees may close their subscriptions earlier than March 8, 2023. Complete terms and conditions for the warrants are available on the Company’s website, www.izafegroup.com.
Summarized terms for the warrants of series TO13B:
Exercise period: February 23, 2023 – March 8, 2023.
Exercise price: SEK 0.20 per share of series B.
Issue size: 118,556,833 warrants of series TO13B, which entitles to subscription of 118,556,833 shares of series B. If all the warrants are exercised, the Company will receive approximately SEK 23.7 million before issuing costs.
Last day for trading warrants of series TO13B: March 6, 2023.
Share capital and dilution: If all warrants are exercised the share capital will increase with SEK 23,711,366.60, from SEK 30,756,066.00 to SEK 54,467,432.60. If all warrants are exercised the number of shares will increase with 118,556,833 shares of series B, in total the number of shares in the Company will increase from 153,780,330 shares to 272,337,163 shares (600,000 shares of series A and 271,737,163 shares of series B). The dilution at full exercise of all warrants amounts to approximately 43.53 percent of the number of shares and 42.69 percent of the votes in the Company.
Note that the warrants of series TO13B that are not exercised at the latest March 8, 2023, or sold at the latest March 6, 2023, will expire without value. For the warrants not to lose their value, the holder must actively subscribe for new shares or sell the warrants. Please note that some trustees may close their registration earlier than 8 March 2023.
Advisors
Mangold Fondkommission AB is the financial advisor and Eversheds Sutherland Advokatbyrå AB is the legal advisor to the Company in connection with the exercise of the warrants of series TO13B.